Metronomic chemotherapy: a systematic review of the literature and clinical experience
Metronomic chemotherapy, continuous and dose‐dense administration of chemotherapeutic
drugs with lowered doses, is being evaluated for substituting, augmenting, or appending …
drugs with lowered doses, is being evaluated for substituting, augmenting, or appending …
Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence
L Lee, T Ito, RT Jensen - Expert opinion on pharmacotherapy, 2018 - Taylor & Francis
Introduction: Since the initial approval of everolimus in 2011, there have been a number of
important changes in therapeutic/diagnostic modalities as well as classification/staging …
important changes in therapeutic/diagnostic modalities as well as classification/staging …
ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN …
M Pavel, D O''Toole, F Costa, J Capdevila… - …, 2016 - karger.com
M. Pavel a D. O'Toole b F. Costa c J. Capdevila d D. Gross e R. Kianmanesh f E. Krenning g
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
E Baudin, M Caplin, R Garcia-Carbonero… - Annals of …, 2021 - annalsofoncology.org
The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …
Phase III prospective randomized comparison trial of depot octreotide plus interferon alfa-2b versus depot octreotide plus bevacizumab in patients with advanced …
JC Yao, KA Guthrie, C Moran, JR Strosberg… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Treatment options for neuroendocrine tumors (NETs) remain limited. This trial
assessed the progression-free survival (PFS) of bevacizumab or interferon alfa-2b (IFN-α …
assessed the progression-free survival (PFS) of bevacizumab or interferon alfa-2b (IFN-α …
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
AT Phan, DM Halperin, JA Chan, DR Fogelman… - The Lancet …, 2015 - thelancet.com
Background Treatment options for advanced, well-differentiated neuroendocrine tumours
(NETs) remain scarce. Pazopanib is an orally bioavailable, small molecule, multitargeted …
(NETs) remain scarce. Pazopanib is an orally bioavailable, small molecule, multitargeted …
Oxaliplatin-based chemotherapy in advanced neuroendocrine tumors: clinical outcomes and preliminary correlation with biological factors
F Spada, L Antonuzzo, R Marconcini, D Radice… - …, 2016 - karger.com
Purpose: The role of chemotherapy in low-/intermediate-grade neuroendocrine tumors
(NETs) is still debated. We present the results of an Italian multicenter retrospective study …
(NETs) is still debated. We present the results of an Italian multicenter retrospective study …
[PDF][PDF] S2k-leitlinie neuroendokrine tumore
A Rinke, B Wiedenmann, C Auernhammer… - Z …, 2018 - register.awmf.org
This guideline was created for the first time and is intended as a practical aid for the
diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of …
diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of …
Current and emerging therapies for PNETs in patients with or without MEN1
M Frost, KE Lines, RV Thakker - Nature Reviews Endocrinology, 2018 - nature.com
Pancreatic neuroendocrine tumours (PNETs) might occur as a non-familial isolated
endocrinopathy or as part of a complex hereditary syndrome, such as multiple endocrine …
endocrinopathy or as part of a complex hereditary syndrome, such as multiple endocrine …
[HTML][HTML] Gastric neuroendocrine tumor: a practical literature review
GA Roberto, CMB Rodrigues, RDA Peixoto… - World Journal of …, 2020 - ncbi.nlm.nih.gov
Gastric neuroendocrine tumors are gastric neoplasms originating from enterochromaffin type
cells and are inserted in a larger group, named gastroenteropancreatic neuroendocrine …
cells and are inserted in a larger group, named gastroenteropancreatic neuroendocrine …